$13.37
Oral Antidiabetic Combination (SGLT2 Inhibitor + Biguanide)
DAPASMART 10/500mg Tablet contains two medicines: dapagliflozin and metformin, both belonging to the class of oral antidiabetics. It is prescribed for adults with type 2 diabetes mellitus when blood sugar cannot be adequately controlled with diet, exercise, or other medicines.
By lowering blood sugar levels, DAPASMART helps prevent long-term complications of diabetes, including kidney damage, cardiovascular disease, nerve problems, vision loss, and risk of amputations.
DAPASMART is prescribed to:
Not applicable.
⚠️ Lactic Acidosis Risk Warning (Metformin Component)
This medicine may rarely cause a serious condition called lactic acidosis (excess lactic acid in the blood), which can be life-threatening.
⚠️ Special Note on Dehydration & Infections (Dapagliflozin Component)
This medicine may increase the risk of:
Drink plenty of fluids and maintain good hygiene to reduce these risks.
Common side effects may include:
Seek medical attention if side effects persist or worsen.












